financetom
Business
financetom
/
Business
/
Aktis to collaborate with Eli Lilly on cancer therapies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aktis to collaborate with Eli Lilly on cancer therapies
May 21, 2024 4:29 AM

May 21 (Reuters) - Aktis Oncology said on Tuesday it

will collaborate with Eli Lilly ( LLY ) to develop cancer

therapies, making it eligible for milestone payments of up to

$1.1 billion and royalties on sales.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved